Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain
NCT00034710 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 42
Last updated 2006-02-07
Summary
The purpose of this study is to gain initial information on the tolerability of high-dose capsaicin patches in patients with Painful Postherpetic Neuralgia. The study will also collect preliminary information on safety and efficacy.
Conditions
- Neuralgia
- Pain
- Peripheral Nervous System Diseases
- Herpes Zoster
Interventions
- DRUG
-
Capsaicin Patch
Sponsors & Collaborators
-
NeurogesX
lead INDUSTRY
Principal Investigators
-
John A Jermano · NeurogesX
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-03-31
- Completion
- 2002-10-31
Countries
- United States
Study Locations
More Related Trials
-
Study of NGX-4010 for the Treatment of Postherpetic Neuralgia
NCT00300222 ·Status: COMPLETED ·Phase: PHASE3
-
Study of [S,S]-Reboxetine in Patients With Postherpetic Neuralgia, Who Are Gabapentin Treatment Failures
NCT00143442 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain
NCT00089557 ·Status: TERMINATED ·Phase: PHASE2
-
The Study of GW493838, an Adenosine A1 Agonist, in Peripheral Neuropathic Pain
NCT00376454 ·Status: COMPLETED ·Phase: PHASE2
-
Injection Therapy for Neuropathic Pain
NCT05809700 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Study of Z160 in Subjects With Postherpetic Neuralgia
NCT01757873 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study of High-Concentration Capsaicin Patches in the Treatment of Painful HIV-Associated Neuropathy
NCT00061152 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety, Tolerability and Pharmacokinetics of Multiple Doses of AV-101 in Healthy Volunteers
NCT01483846 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
NCT01748877 ·Status: COMPLETED ·Phase: PHASE2
-
Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN)
NCT00233155 ·Status: COMPLETED ·Phase: PHASE2
-
Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain
NCT00082316 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Preliminary Efficacy of MK0759 in Postherpetic Neuralgia (PHN)(0759-004)
NCT00245544 ·Status: TERMINATED ·Phase: PHASE2
-
A Comparison of EpiCept™ NP-1 Topical Cream vs. Oral Gabapentin in Postherpetic Neuralgia (PHN)
NCT00475904 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Determine if an Investigational Pain Medicine Provides Relief of Chronic Pain After a Shingles Outbreak
NCT00506610 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy
NCT00064623 ·Status: COMPLETED ·Phase: PHASE3
-
Study of NGX-1998 for the Treatment of Postherpetic Neuralgia
NCT01228838 ·Status: COMPLETED ·Phase: PHASE2
-
Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy
NCT00085761 ·Status: TERMINATED ·Phase: PHASE3
-
Evolution of Pain From Herpes Zoster
NCT00305357 ·Status: COMPLETED
-
Study of NGX-4010 With the Use of Open Label Lidocaine (2.5%)/Prilocaine (2.5%) Cream for the Treatment of Postherpetic Neuralgia (PHN)
NCT00916942 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Capsaicin Patch for the Management of Peripheral Neuropathic Pain
NCT02228928 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dose-Tolerability Titration Study to Evaluate The Efficacy And Safety Of Perampanel (E2007) In Patients With Post-Herpetic Neuralgia (PHN)
NCT00592774 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Effects of Topical Capsaicin in the Treatment of Provoked Vestibulodynia
NCT02854670 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral Neuropathy
NCT05840562 ·Status: RECRUITING ·Phase: PHASE3
-
A Study With Lido-Patch and Placebo Plaster in Patients Suffering From Postherpetic Neuralgia (PHN)
NCT03745404 ·Status: COMPLETED ·Phase: PHASE3
-
Study of a Bupivacaine Patch (Eladur™) to Treat Post- Herpetic Neuralgia
NCT00478179 ·Status: COMPLETED ·Phase: PHASE2